Impact of Biological Therapies on the Immune Response after Pneumococcal Vaccination in Patients with Autoimmune Inflammatory Diseases

Patients with different autoimmune inflammatory diseases (AIID) on biological therapy are at risk of pneumococcal disease. Adults with inflammatory arthropathies, connective tissue diseases, psoriasis, or inflammatory bowel disease on biological therapy such as anti-TNFα, rituximab, tocilizumab, aba...

Descripción completa

Detalles Bibliográficos
Autores principales: Richi, Patricia, Yuste, Jose, Navío, Teresa, González-Hombrado, Laura, Salido, Marina, Thuissard-Vasallo, Israel, Jiménez-Díaz, Ana, Llorente, Jesús, Cebrián, Laura, Lojo, Leticia, Steiner, Martina, Cobo, Tatiana, Martín, María Dolores, García-Castro, Marta, Castro, Patricia, Muñoz-Fernández, Santiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997274/
https://www.ncbi.nlm.nih.gov/pubmed/33671007
http://dx.doi.org/10.3390/vaccines9030203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997274/
https://www.ncbi.nlm.nih.gov/pubmed/33671007
http://dx.doi.org/10.3390/vaccines9030203

Ejemplares similares